🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
303.01265.31190.17165.83139.487.67
Depreciation & Amortization
38.6132.0326.8527.2429.0532.31
Other Amortization
0.110.110.180.370.530.59
Loss (Gain) From Sale of Assets
--0-13.62-1.03-
Stock-Based Compensation
1.693.136.697.6913.482.45
Provision & Write-off of Bad Debts
-1.29-7.3214.470.24.723.02
Other Operating Activities
-12.985.754.78-5.415.371.28
Change in Accounts Receivable
2.25-31.02-29.78-3.8-12.26-6
Change in Inventory
-10.48-23.469.45-9.913.688.03
Change in Accounts Payable
-15.7236.8432.87-18.82-4.117.05
Change in Unearned Revenue
-8-7.8321.6-2.92-6.887.36
Change in Other Net Operating Assets
1.1916.6920.9624.3386.38-26.18
Operating Cash Flow
298.38290.22298.22171.2268.34117.59
Operating Cash Flow Growth
7.73%-2.68%74.20%-36.20%128.19%57.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-73.82-81.87-31.77-22.44-14.29-14.26
Sale of Property, Plant & Equipment
---0.96.28-
Sale (Purchase) of Intangibles
-0.07-0.77---0.15-1.19
Sale (Purchase) of Real Estate
---22.59--
Investment in Securities
-250-300--491.2716.56-13.74
Other Investing Activities
-8.2-0.362.7-0.032.0426.41
Investing Cash Flow
-332.08-382.99-29.07-490.2510.43-2.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-100----
Total Debt Issued
100100----
Long-Term Debt Repaid
-----0.95-2.49
Lease Payments
-----0.95-2.49
Net Debt Issued (Repaid)
-100---0.95-2.49
Issuance of Common Stock
0.590.3928.690.96-247.35
Common Dividends Paid
-171.84-74.43-88.96-42.35--56.27
Dividends Paid
-171.84-74.43-88.96-42.35--56.27
Other Financing Activities
-4.034.70.54--0.10.1
Financing Cash Flow
-175.2930.66-59.73-41.39-1.05188.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-8.64-0.75-1.450.57-0.080.03
Net Cash Flow
-217.63-62.86207.97-359.87277.64303.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
224.56208.36266.45148.76254.05103.34
Free Cash Flow Growth
0.46%-21.80%79.12%-41.44%145.85%61.91%
Free Cash Flow Margin
26.21%25.67%39.15%23.91%42.03%20.18%
Free Cash Flow Per Share
2.482.312.971.662.841.22
Levered Free Cash Flow
104.03105.01186.0891.4209.6971.5
Unlevered Free Cash Flow
104.22105.03186.0891.4209.7371.62
Free Cash Flow After Leases
224.56208.36266.45148.76253.1100.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.040.04--0.070.2
Cash Income Tax Paid
33.8333.8330.632.7210.768.52
Change in Working Capital
-30.76-8.7855.09-11.1266.81-9.73